Philips Azurion 3 M15 Recall for X-ray Imaging Issues
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Philips is recalling 798 units of the Azurion 3 M15 medical device due to potential failures in initiating X-ray imaging with the wired foot switch.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 15, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Philips has identified instances where X-ray imaging may not be initiated or may occur intermittently when using the wired foot switch.
Which Products Are Affected
The affected products are Azurion 3 M15 with System Codes: (1) 722064, (2) 722222, (3) 722230, and (4) 722280. The recall involves 798 units total, with 42 in the US and 756 outside the US. Specific UDIs include: (1) 00884838085282, (2) 00884838099210, (3) 00884838116733, and (4) 00884838103276. Numerous serial numbers are associated with each system code as listed in the recall notice. Distribution occurred nationwide in the US and to various international countries.
What You Should Do
Consumers should follow the initial firm notification, which was issued via letter, and contact the recalling firm, Philips Medical Systems Nederland B.V., located at Veenpluis 6, Best, Netherlands, for further instructions on the voluntary recall.
Why This Matters
This recall highlights potential risks in medical devices that could affect imaging procedures, emphasizing the importance of reliable equipment in healthcare settings.
Source
FDA Recall Number: Z-1674-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,156 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 15, 2026.
Frequently Asked Questions
Common questions about this FDA recall.